According to the literature, patients with psoriasis have an increased expression of the gene responsible for coding the type II membrane protein, a type of sialyltransferase, which catalyzes the transfer of sialic acid to glycolipids to produce the gangliosides GD3 and GT3 [59,60,61]. This evidence concerns the gene RXYLT1 and psoriasis.